Severability Clause Example from Business Contracts
This example Severability clause appears in 22 contracts from 12 companies
Assignment and Assumption Agreement effective as of May 8, 2019 between Mobiquity Technologies, Inc. and Gopher Protocol, Inc (Filed With SEC on May 16, 2019)
Amendment No. 1 to the Amended and Restated Series D Preferred Stock Investors Rights and Stockholders Agreement, dated April 17, 2020, by and among SelectQuote, Inc. and certain... (Filed With SEC on May 8, 2020)
8% Convertible Promissory Note, from Specialty Renal Products, Inc. to the Company, dated October 7, 2020 (Filed With SEC on October 13, 2020)
Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and PFM Health Sciences, LP (Filed With SEC on July 1, 2021)
Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and Ridgeback Capital Investments LP (Filed With SEC on July 1, 2021)
Public Offering Participation Rights Agreement, dated March 2, 2021, by and between the Registrant and Zone III Healthcare Holdings, LLC (Filed With SEC on July 1, 2021)
Exchange Agreement dated July 7, 2021 among the Company, and the Members of Moving iMage Technologies, LLC (Filed With SEC on July 13, 2021)
Secured Convertible Promissory Note dated July 20, 2018 between EVO Transportation & Energy Services, Inc. and Dan Thompson II LLC (Filed With SEC on August 6, 2018)
SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 6, 2017)
SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 6, 2017)
SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 6, 2017)
SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 6, 2017)
Convertible Promissory Note, dated February 22, 2018 (Filed With SEC on May 25, 2018)
6% Convertible Note, dated October 6, 2015, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson (Filed With SEC on February 14, 2017)
6% Convertible Note, dated October 28, 2015, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD (Filed With SEC on February 14, 2017)
6% Convertible Note, dated December 23, 2015, among Adgero Biopharmaceuticals, Inc. and Adam Stern (Filed With SEC on February 14, 2017)
Form of OrangeHook, Inc. Amended and Restated Convertible Promissory Note (Filed With SEC on December 5, 2016)
Promissory Note, dated June 21, 2017, between OrangeHook, Inc. and Donald Miller (Filed With SEC on August 14, 2017)
AMENDMENT AGREEMENT (Filed With SEC on April 6, 2016)
AMENDMENT AGREEMENT (Filed With SEC on June 8, 2016)
NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on September 11, 2014)
CONSULTING AGREEMENT (Filed With SEC on July 30, 2015)
